duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - ravimid hingamisteede obstruktiivsete haiguste, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
elebrato ellipta
glaxosmithkline trading services limited - flutikasoonfuroaat, umeklidiiniumbromiid, vilanterooltripenataat - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - elebrato ellipta on näidustatud säilitusraviks keskmise või raske krooniline obstruktiivne kopsuhaigus (kok) täiskasvanud patsientidel, kes ei käsitleta piisavalt inhaleeritava kortikosteroidi ja pikatoimelise beeta2-agonisti.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
budesonide/formoterol teva pharma b.v.
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - asthma; pulmonary disease, chronic obstructive - ravimid hingamisteede obstruktiivsete haiguste, - budesonide / formoterol teva pharma b. on näidustatud ainult 18-aastastel ja vanematel täiskasvanutel. asthmabudesonide/formoterol teva pharma b. on näidustatud regulaarne astma raviks, kui kasutada kombinatsiooni (inhaleeritava kortikosteroidi ja pika toimeajaga β2 adrenoceptor agonist) on asjakohane:-patsientidel ei ole piisavalt kontrollitud inhaleeritava kortikosteroide ja "nii nagu vaja" sisse hingata lühikese toimeajaga β2 adrenoceptor agonistid. või-patsientidel, juba piisavalt kontrollitud, nii inhaleeritava kortikosteroide ja pika toimeajaga β2 adrenoceptor agonistid. copdsymptomatic patsientide ravi copd koos forced expiratory volume in 1 sekundi jooksul (fev1) .
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
incruse ellipta (previously incruse)
glaxosmithkline (ireland) limited - umeklidiiniumbromiid - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - kroonilise obstruktiivse kopsuhaiguse (kok) täiskasvanud patsientide sümptomite leevendamiseks on näidustatud bronhodilataatori hooldus.
laventair ellipta (previously laventair)
glaxosmithkline (ireland) limited - umeclidinium bromiid, vilanterol - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - laventair ellipta on näidustatud hooldus bronchodilator ravi, et leevendada sümptomeid täiskasvanud patsientidel, kellel on krooniline obstruktiivne kopsuhaigus (copd).
rolufta ellipta (previously rolufta)
glaxosmithkline trading services limited - umeklidiiniumbromiid - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - rolufta on näidustatud kroonilise obstruktiivse kopsuhaiguse (kok) täiskasvanud patsientide sümptomite leevendamiseks bronhodilataatorite hoolduseks.
bropair spiromax
teva b.v. - salmeterol xinafoate, fluticasone propionaat - astma - ravimid hingamisteede obstruktiivsete haiguste, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.